Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Head & Neck 1CNS 1

Conditions

Breast Neoplasms 30Central Nervous System Neoplasms 18Rectal Neoplasms 15Colorectal Neoplasms 15Lung Neoplasms 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Gliosarcoma 7Neoplasm Metastasis 6Esophageal Neoplasms 6Brain Neoplasms 6Adenocarcinoma Of Esophagus 6Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 5Breast Carcinoma In Situ 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Mesothelioma, Malignant 4Kidney Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Solitary Fibrous Tumor, Pleural 3Prostatic Neoplasms 3Ovarian Neoplasms 3

Interventions

Cyclophosphamide 241Rituximab 223Etoposide 138Filgrastim 113Vincristine 112Doxorubicin 104Prednisone 90Cytarabine 90Methotrexate 79fludarabine phosphate 77Radiotherapy 76Peripheral Blood Stem Cell Transplantation 71Melphalan 71Busulfan 60Tacrolimus 48Dexamethasone 48Mycophenolic Acid 46Carmustine 46Granulocyte Colony-Stimulating Factor 44fludarabine 43Antilymphocyte Serum 40Ifosfamide 38sargramostim 34Whole-Body Irradiation 34Cyclosporine 33Bortezomib 32Gemcitabine 30Methylprednisolone 27Bendamustine Hydrochloride 27Lenalidomide 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma × Chemotherapy, Adjuvant × Clear all
NCT00006478 2023-09-18

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

University of Nebraska

Phase 2 Terminated
19 enrolled 4 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00242996 2017-09-28

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
44 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡